Oncology R&D Boosts Korean Clinical Trials In 2015
This article was originally published in PharmAsia News
Executive Summary
With South Korean pharma firms and drug developers striving to turn into innovators, the number of clinical trials approved by regulatory authorities climbed last year, led by studies for cancer therapies, particularly those acting on the immune system, one of the most active research areas globally.